المؤلفون: Corina van den Hurk, Annemarie Becker-Commissaris, Vashti N. M. F. Tromp, Iris Walraven, Nicole E Billingy

المساهمون: Pulmonary medicine, Clinical pharmacology and pharmacy, CCA - Cancer Treatment and quality of life, Ophthalmology, APH - Quality of Care, APH - Aging & Later Life

المصدر: Cancers
Volume 13
Issue 17
Cancers, 13(17):4282. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13, 17
Billingy, N E, Tromp, V N M F, van den Hurk, C J G, Becker-Commissaris, A & Walraven, I 2021, ' Health-Related Quality of Life and Survival in Metastasized Non-Small Cell Lung Cancer Patients with and without a Targetable Driver Mutation ', Cancers, vol. 13, no. 17, 4282 . https://doi.org/10.3390/cancers13174282Test
Cancers, Vol 13, Iss 4282, p 4282 (2021)
Cancers, 13

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Article, Gee, All institutes and research themes of the Radboud University Medical Center, Quality of life, Internal medicine, medicine, Lung cancer, Generalized estimating equation, Survival analysis, RC254-282, non-small cell lung cancer, Health related quality of life, business.industry, metastatic lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, humanities, health-related quality of life, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Observational study, Non small cell, business, targetable driver mutation

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5214ee4729ef478ba1c5e7c67ee702baTest

المؤلفون: Adnan Akbar, Nirmesh Patel, Ionut Dragomir, Harry W. Clifford, John W. Cassidy, Gianmarco Contino

المساهمون: Dragomir, Ionut [0000-0003-0509-6761], Contino, Gianmarco [0000-0001-5874-0405], Apollo - University of Cambridge Repository

المصدر: Cancers, Vol 13, Iss 2779, p 2779 (2021)
Cancers
Volume 13
Issue 11

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Computer science, Decision tree, pan-cancer, Genomics, Machine learning, computer.software_genre, Article, support vector machines, 03 medical and health sciences, 0302 clinical medicine, k-nearest neighbours, decision tree, Feature (machine learning), multilayer perceptron, RC254-282, business.industry, logistic regression, driver mutation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Precision medicine, Random forest, Support vector machine, Statistical classification, 030104 developmental biology, Oncology, classification, 030220 oncology & carcinogenesis, Multilayer perceptron, extreme gradient boosting, Artificial intelligence, business, computer, random forest

وصف الملف: application/zip; text/xml; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::424f14e322eaf17edcba8483f856177fTest
https://pubmed.ncbi.nlm.nih.gov/34205004Test

المؤلفون: Lukas C. Heukamp, Balázs Jóri, S. Schatz, Eva-Maria Willing, Matthias Kröger, Harry J.M. Groen, Linda Diehl, Stefanie Schmidt, Markus Falk, Hayat Oum El Kheir Ramdani, Frank Griesinger, Markus Tiemann, C. Wesseler, Roopika Menon, Petra Hoffknecht

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Cancers, 12(6):1685, 1-14. MDPI AG
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1685, p 1685 (2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, PD-L1, Cancer Research, medicine.medical_specialty, tumor mutational burden, BLOCKADE, NEOANTIGENS, PHASE-1, medicine.disease_cause, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, IMMUNOHISTOCHEMISTRY, Lung cancer, immuno-oncology, Mutation, biology, business.industry, driver mutation, Routine laboratory, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, routine diagnostics, OPEN-LABEL, EFFICACY, Immune checkpoint, respiratory tract diseases, lung cancer, 1ST-LINE TREATMENT, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, NIVOLUMAB PLUS IPILIMUMAB, Biomarker (medicine), Non small cell, Antibody, SENSITIVITY, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8ac4497f7a0a8ca98d267c72164bc1Test
https://research.rug.nl/en/publications/3f08a1fc-fe7c-4f77-9a0f-80bf8ce9b9c8Test

المؤلفون: Yuichi Ishikawa, Sophia Subat, Hironori Ninomiya, Sakae Okumura, Kentaro Inamura, Hiroko Nagano

المصدر: Journal of Clinical Medicine, Vol 7, Iss 11, p 419 (2018)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 7; Issue 11; Pages: 419

مصطلحات موضوعية: 0301 basic medicine, EGFR, precision medicine, lcsh:Medicine, medicine.disease_cause, Article, noncoding RNA, 03 medical and health sciences, non-small-cell lung carcinoma (NSCLC), tyrosine kinase inhibitor, 0302 clinical medicine, microRNA, Medicine, Gene, EGFR inhibitors, integrative association, messenger RNA, business.industry, driver mutation, lcsh:R, molecular-targeted therapy, General Medicine, medicine.disease, Non-coding RNA, Gene expression profiling, tumorigenesis, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, Adenocarcinoma, DNA microarray, business, Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a77e0bd9fbd6b9863e8530e362ddd60Test
https://doi.org/10.3390/jcm7110419Test

المؤلفون: Tomoya Yokota

المصدر: Anti-Cancer Agents in Medicinal Chemistry

مصطلحات موضوعية: Oncology, MAPK/ERK pathway, Cancer Research, endocrine system diseases, Colorectal cancer, Predictive marker, Cetuximab, medicine.disease_cause, 0302 clinical medicine, Genotype, 0303 health sciences, Mutation, Panitumumab, Prognosis, Phenotype, 3. Good health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Molecular Medicine, KRAS, Colorectal Neoplasms, medicine.drug, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Prognostic biomarker, Colon, EGFR, Rectum, Article, BRAF, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Internal medicine, Proto-Oncogene Proteins, medicine, Biomarkers, Tumor, Screening, Animals, Humans, Chemotherapy, KRAS p.G13D, Anti-EGFR monoclonal antibody, KRAS codon 12, KRAS codon 13, neoplasms, 030304 developmental biology, Pharmacology, business.industry, Driver mutation, medicine.disease, digestive system diseases, Cancer research, ras Proteins, business, Clinicopathological features

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10bf73b562f455a04cc1cd10de277cf1Test
https://pubmed.ncbi.nlm.nih.gov/22043994Test